ODOMZO: payments to doctors
Payments that named ODOMZO as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $2.3M
- Providers
- 10,341
- Transactions
- 27,679
- Average per transaction
- $84
The per-transaction average — $84 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 10,341 providers the average total is $224, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| SUN Pharmaceutical Industries Inc. | $1,448,710 | 62.4% |
| Sun Pharmaceutical Industries Inc. | $847,411 | 36.5% |
| DUSA Pharmaceuticals, Inc. | $24,375 | 1.1% |